253 related articles for article (PubMed ID: 28453897)
1. Clinical outcome of childhood chronic immune thrombocytopenia: A 38-year experience from a single tertiary center in Thailand.
Chotsampancharoen T; Sripornsawan P; Duangchoo S; Wongchanchailert M; McNeil E
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28453897
[TBL] [Abstract][Full Text] [Related]
2. Prognostic variables in newly diagnosed childhood immune thrombocytopenia.
Ahmed S; Siddiqui AK; Shahid RK; Kimpo M; Sison CP; Hoffman MA
Am J Hematol; 2004 Dec; 77(4):358-62. PubMed ID: 15551294
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for resolution of childhood immune thrombocytopenia: Experience from a single tertiary center in Thailand.
Chotsampancharoen T; Sripornsawan P; Duangchoo S; Wongchanchailert M; McNeil E
Pediatr Blood Cancer; 2017 Jan; 64(1):128-134. PubMed ID: 27571705
[TBL] [Abstract][Full Text] [Related]
4. Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants.
Bennett CM; Neunert C; Grace RF; Buchanan G; Imbach P; Vesely SK; Kuhne T
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28792679
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
[TBL] [Abstract][Full Text] [Related]
6. High Remission Rate of Chronic Immune Thrombocytopenia in Children: Result of 20-Year Follow-Up.
Kim CY; Lee EH; Yoon HS
Yonsei Med J; 2016 Jan; 57(1):127-31. PubMed ID: 26632392
[TBL] [Abstract][Full Text] [Related]
7. Outcome of chronic idiopathic thrombocytopenic purpura in children.
Bansal D; Bhamare TA; Trehan A; Ahluwalia J; Varma N; Marwaha RK
Pediatr Blood Cancer; 2010 Mar; 54(3):403-7. PubMed ID: 19908301
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of response to IVIG in pediatric immune thrombocytopenic purpura.
Higashide Y; Hori T; Yoto Y; Kabutoya H; Honjo S; Sakai Y; Nojima M; Yoda M; Yamamoto M; Tsutsumi H
Pediatr Int; 2018 Apr; 60(4):357-361. PubMed ID: 29297955
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
11. Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months.
Revel-Vilk S; Yacobovich J; Frank S; Ben-Ami T; Yechieli M; Shkalim V; Lebel A; Semo-Oz R; Tamary H
J Pediatr; 2013 Nov; 163(5):1335-9.e1-2. PubMed ID: 23891349
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic thrombocytopenic purpura: a 15-year natural history study at the Children's Hospital Rijeka, Croatia.
Roganovic J; Letica-Crepulja M
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):662-4. PubMed ID: 16933251
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of chronic idiopathic thrombocytopenia in Chinese children.
Wong MS; Chan GC; Ha SY; Lau YL
J Pediatr Hematol Oncol; 2002 Nov; 24(8):648-52. PubMed ID: 12439037
[TBL] [Abstract][Full Text] [Related]
14. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome.
Medeiros D; Buchanan GR
J Pediatr; 1998 Sep; 133(3):334-9. PubMed ID: 9738712
[TBL] [Abstract][Full Text] [Related]
15. [Childhood idiopathic thrombocytopenic purpura (the results of 20-year experience)].
Kvezereli-Kopadze MA; Kvezereli-Kopadze AN; Mtvarelidze ZG
Georgian Med News; 2009 Sep; (174):50-5. PubMed ID: 19801732
[TBL] [Abstract][Full Text] [Related]
16. Influence of the American Society of Hematology guidelines on the management of newly diagnosed childhood immune thrombocytopenia.
Schultz CL; Mitra N; Schapira MM; Lambert MP
JAMA Pediatr; 2014 Oct; 168(10):e142214. PubMed ID: 25288142
[TBL] [Abstract][Full Text] [Related]
17. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).
Tamminga R; Berchtold W; Bruin M; Buchanan GR; Kühne T
Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia.
Chen YY; Zhou YQ; Zhao N; Zhang Y; Xu WQ; Tang YM
Cytokine; 2019 Aug; 120():234-241. PubMed ID: 31129375
[TBL] [Abstract][Full Text] [Related]
19. [What is the prognosis of chronic immune thrombocytopenia?].
Calleja Gero ML; Sevilla J; Madero L
An Pediatr (Barc); 2011 May; 74(5):317-23. PubMed ID: 21334273
[TBL] [Abstract][Full Text] [Related]
20. [Influencing Factors in the Chronicity of Immune Thrombocytopenia in Children].
Wang LY; Liu KK; Chu JH; Yang LH; Xie ZW; Zhang KL; Chai HJ; Wu ZY; Wang NL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):881-886. PubMed ID: 34105488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
